{"id":"W1976794477","doi":"10.1007/s11912-013-0303-y","title":"Benefit and Harms of New Anti-Cancer Drugs","year":2013,"lang":"en","type":"review","venue":"Current Oncology Reports","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Drug; Randomized controlled trial; Clinical endpoint; Intensive care medicine; Clinical trial; Biomarker; Cancer drugs; Cancer; Oncology; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002625884,0.0005225999,0.005785485,0.0001439439,0.00003985714,0.00002173951,0.0002532545,0.0008283855,0.001186932],"category_scores_gemma":[0.02421138,0.0003766981,0.0005801625,0.0002113349,0.0003435322,0.00004636786,0.0003536706,0.0008545327,0.00002582535],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001457552,"about_ca_system_score_gemma":0.0009507815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001572867,"about_ca_topic_score_gemma":9.915707e-7,"domain_scores_codex":[0.9942457,0.0005903154,0.003597885,0.0008269648,0.0003539924,0.0003851078],"domain_scores_gemma":[0.9732929,0.02107975,0.004254273,0.0008377412,0.000197248,0.0003380433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000001819218,0.0002184604,0.0000380044,0.01786844,0.000227508,0.00003689362,0.00004026587,1.996017e-8,2.636097e-7,0.002842339,0.01983061,0.9588954],"study_design_scores_gemma":[0.000183586,0.00007506683,0.000004814617,0.007365124,0.001845842,0.0001143965,0.000003508402,5.697214e-7,0.000003768224,0.2421763,0.7480032,0.0002238679],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004662406,0.9901518,0.001114292,0.00004381949,0.005975385,0.001802543,0.00007623473,0.00005558342,0.0007337564],"genre_scores_gemma":[4.08207e-7,0.8808982,0.1170036,0.00001193929,0.0008222022,0.000250411,0.000009872054,0.00006754289,0.0009357996],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9586715,"threshold_uncertainty_score":0.9998685,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.816919546873807,"score_gpt":0.6846755958939144,"score_spread":0.1322439509798926,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}